Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

17.75
-0.3200-1.77%
Post-market: 17.920.1677+0.94%19:30 EDT
Volume:1.07M
Turnover:19.00M
Market Cap:36.49B
PE:9.33
High:18.07
Open:17.89
Low:17.54
Close:18.07
52wk High:18.19
52wk Low:8.57
Shares:2.06B
Float Shares:237.00M
Volume Ratio:0.71
T/O Rate:0.45%
Dividend:0.99
Dividend Rate:5.58%
EPS(TTM):1.90
EPS(LYR):1.16
ROE:15.95%
ROA:7.31%
PB:1.78
PE(LYR):15.24

Loading ...

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

GlobeNewswire
·
Apr 09

Ecopetrol Board Approves President's Unpaid Leave of Absence

MT Newswires Live
·
Apr 07

Market Chatter: Ecopetrol Grants CEO Ricardo Roa Extended Holiday, Unpaid Leave of Absence

MT Newswires Live
·
Apr 07

Ecopetrol Receives Approval for $1.25 Billion Loan to Refinance Debt

MT Newswires Live
·
Apr 06

Rhythm Pharmaceuticals Announces Changes to Board of Directors

GlobeNewswire
·
Apr 03

EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis

GlobeNewswire
·
Mar 31

China Securities: Profitability in VC and EC Segments Expected to Improve, Focus on High-Beta Stocks

Stock News
·
Mar 30

588-unit Pinery Residences sells 92.5% of units at over $2,500 psf average on launch day

Gerine Tang Yi Qian
·
Mar 28

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment

GlobeNewswire
·
Mar 26

Shrinking EUA supply puts EU ETS under policy strain

Fastmarkets
·
Mar 26

Ecopetrol Says No Violations, Contract Breaches to Date Related to Formal Charges Against President Ricardo Roa

MT Newswires Live
·
Mar 26

Ecopetrol says ‘committed’ to safeguarding interests of company, shareholders

TIPRANKS
·
Mar 25

EC urged to stop Fifa’s ‘aggressive and exploitative’ World Cup ticket prices

cityam
·
Mar 24

Ecopetrol price target raised to $13 from $8.70 at Goldman Sachs

TIPRANKS
·
Mar 23

Press Release: Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations

Dow Jones
·
Mar 20

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

GlobeNewswire
·
Mar 20

Press Release: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Dow Jones
·
Mar 19

S’pore private residential market to remain resilient despite Mideast tensions: HSBC

Jovi Ho
·
Mar 19

Press Release: Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results

Dow Jones
·
Mar 18

Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026

GlobeNewswire
·
Mar 18